Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc

XENE

Market Cap$2.46B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Xenon Pharmaceuticals IncXenon Pharmaceuticals Inc-10--36%--
$42.00

Target Price by Analysts

29.6% upsideXenon Pharmaceuticals Target Price DetailsTarget Price
$1.72

Current Fair Value

94.7% downside

Overvalued by 94.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.46 Billion
Enterprise Value$2.35 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.01
Beta1.1
Outstanding Shares78,687,503

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.03
PEG-28.09
Price to Sales-
Price to Book Ratio4.05
Enterprise Value to Revenue313.51
Enterprise Value to EBIT-8.03
Enterprise Value to Net Income-10
Total Debt to Enterprise0
Debt to Equity0.01

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Xenon Pharmaceuticals Inc

CEO: Simon Pimstone